Iliocaval and iliofemoral venous stenting for obstruction secondary to tumor compression.

IF 1.2 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS CVIR Endovascular Pub Date : 2024-03-22 DOI:10.1186/s42155-024-00438-6
Ahmed K Aly, Amgad M Moussa, Olivier Chevallier, Sirish Kishore, Elena Petre, Adie Friedman, Yolanda Bryce, Adrian Gonzalez, Juan Camacho, Ernesto Santos, Fourat Ridouani
{"title":"Iliocaval and iliofemoral venous stenting for obstruction secondary to tumor compression.","authors":"Ahmed K Aly, Amgad M Moussa, Olivier Chevallier, Sirish Kishore, Elena Petre, Adie Friedman, Yolanda Bryce, Adrian Gonzalez, Juan Camacho, Ernesto Santos, Fourat Ridouani","doi":"10.1186/s42155-024-00438-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cancer patients with pelviabdominal masses can suffer from lower extremity symptoms due to venous compression. The effectiveness of venous stenting has been established in extrinsic venous compression in benign conditions like May-Thurner syndrome. In this retrospective study we evaluate the efficacy and safety of caval, iliocaval and iliofemoral venous stenting for cases of extrinsic venous compression caused by malignant masses in cancer patients.</p><p><strong>Methods: </strong>IRB-approved retrospective review of patients who underwent iliofemoral venography with venoplasty and stenting between January 2018 and February 2022 was performed. Patients with extrinsic venous compression caused by malignant masses were included. Data on patient demographics, pre-procedure symptoms, procedural technique, stent characteristics, outcomes and follow-up were collected. Descriptive statistics were used to assess technical success, clinical success, primary stent patency and adverse events of the procedure.</p><p><strong>Results: </strong>Thirty-seven patients (19 males, 18 females) who underwent 45 procedures were included. Deep venous thrombosis (DVT) was present in 21 (57%) patients. Twenty-nine patients (78%, 95% CI 62-90%) reported clinical improvement of the presenting symptoms. The median overall survival after the procedure was 4.7 months (95% CI 3.58-5.99). Eight (22%) patients were alive at last follow up with median follow up of 10.33 months (Range 2-25 months). Twenty-six patients had patent stents on their last follow up imaging (70%, 95% CI 61%-91%). Two patients had a small access site hematoma which resolved spontaneously. Two patients developed moderate, and 1 patient developed severe adverse events related to post procedure therapeutic anticoagulation.</p><p><strong>Conclusion: </strong>Venous stenting is a safe procedure and should be considered as part of the palliative care for patients with debilitating lower extremity symptoms related to iliocaval and iliofemoral venous compression.</p>","PeriodicalId":52351,"journal":{"name":"CVIR Endovascular","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2024-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10957860/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CVIR Endovascular","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s42155-024-00438-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cancer patients with pelviabdominal masses can suffer from lower extremity symptoms due to venous compression. The effectiveness of venous stenting has been established in extrinsic venous compression in benign conditions like May-Thurner syndrome. In this retrospective study we evaluate the efficacy and safety of caval, iliocaval and iliofemoral venous stenting for cases of extrinsic venous compression caused by malignant masses in cancer patients.

Methods: IRB-approved retrospective review of patients who underwent iliofemoral venography with venoplasty and stenting between January 2018 and February 2022 was performed. Patients with extrinsic venous compression caused by malignant masses were included. Data on patient demographics, pre-procedure symptoms, procedural technique, stent characteristics, outcomes and follow-up were collected. Descriptive statistics were used to assess technical success, clinical success, primary stent patency and adverse events of the procedure.

Results: Thirty-seven patients (19 males, 18 females) who underwent 45 procedures were included. Deep venous thrombosis (DVT) was present in 21 (57%) patients. Twenty-nine patients (78%, 95% CI 62-90%) reported clinical improvement of the presenting symptoms. The median overall survival after the procedure was 4.7 months (95% CI 3.58-5.99). Eight (22%) patients were alive at last follow up with median follow up of 10.33 months (Range 2-25 months). Twenty-six patients had patent stents on their last follow up imaging (70%, 95% CI 61%-91%). Two patients had a small access site hematoma which resolved spontaneously. Two patients developed moderate, and 1 patient developed severe adverse events related to post procedure therapeutic anticoagulation.

Conclusion: Venous stenting is a safe procedure and should be considered as part of the palliative care for patients with debilitating lower extremity symptoms related to iliocaval and iliofemoral venous compression.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
髂腹腔和髂股静脉支架植入术治疗肿瘤压迫引起的梗阻。
背景:患有盆腹腔肿块的癌症患者会因静脉受压而出现下肢症状。对于梅-图纳综合征等良性疾病的外源性静脉压迫,静脉支架植入术的有效性已经得到证实。在这项回顾性研究中,我们评估了腔静脉、髂腹腔静脉和髂股静脉支架植入术对癌症患者恶性肿块引起的外静脉压迫病例的有效性和安全性:对2018年1月至2022年2月期间接受髂股静脉造影术与静脉成形术和支架植入术的患者进行了IRB批准的回顾性审查。纳入了因恶性肿块导致外静脉压迫的患者。收集了有关患者人口统计学、术前症状、手术技术、支架特征、结果和随访的数据。描述性统计用于评估手术的技术成功率、临床成功率、主要支架通畅率和不良事件:37名患者(19名男性,18名女性)接受了45例手术。21名患者(57%)出现深静脉血栓(DVT)。29名患者(78%,95% CI 62-90%)的临床症状有所改善。术后总生存期的中位数为 4.7 个月(95% CI 3.58-5.99)。八名患者(22%)在最后一次随访时仍存活,中位随访时间为 10.33 个月(2-25 个月)。26 名患者在最后一次随访成像中支架通畅(70%,95% CI 61%-91%)。两名患者出现了小的入路部位血肿,但已自行消退。两名患者出现了中度不良反应,一名患者出现了与术后抗凝治疗相关的严重不良反应:静脉支架植入术是一种安全的手术,对于因髂腹股沟和髂股静脉受压而出现下肢衰弱症状的患者,应考虑将其作为姑息治疗的一部分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CVIR Endovascular
CVIR Endovascular Medicine-Radiology, Nuclear Medicine and Imaging
CiteScore
2.30
自引率
0.00%
发文量
59
期刊最新文献
Feasibility of an antegrade-retrograde single-sheath inverse technique via vertical puncture in dysfunctional hemodialysis arteriovenous fistula angioplasty. Correction: Interventional solutions for post‑surgical problems: a lymphatic leaks review Carbon dioxide-enhanced angiography for detection of colonic diverticular bleeding and clinical outcomes Investigating the effects of percutaneous endovascular aneurysm repair for abdominal aortic aneurysm on the lumen size of the common femoral artery Transjugular antegrade transvenous obliteration, with and without portal decompression, for management of rectal variceal hemorrhage.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1